Key Highlights
- RBC Capital Markets increased its 12-month S&P 500 forecast from 7,750 to 7,900
- The revised forecast represents a potential 7.7% increase from Thursday’s closing price of 7,335.66
- RBC attributes the outlook to a bifurcated economy where artificial intelligence companies lead growth amid broader challenges
- The healthcare sector received a downgrade to Market Weight following negative earnings trends and investor withdrawals
- RBC identified elevated semiconductor valuations and Middle East tensions as primary concerns
RBC Capital Markets announced an increased S&P 500 price forecast of 7,900 on Friday, moving up from its prior estimate of 7,750. Lori Calvasina, RBC’s head of U.S. strategy, established the revised target.
The revision follows a substantial market advance, with the S&P 500 gaining over 16% since reaching its March 30 low point. Based on Thursday’s closing level of 7,335.66, the updated target suggests approximately 7.7% potential appreciation.
RBC derived its latest forecast using its valuation and earnings-per-share framework instead of averaging its five prediction methodologies. The firm explained this approach better represents what they describe as a bifurcated economic landscape.
This characterization reflects market segmentation. Companies tied to artificial intelligence continue delivering robust earnings performance, while other index constituents encounter challenges stemming from Middle East geopolitical tensions.
RBC implemented a 5% reduction to bottom-up earnings projections for the first quarter of 2027, resulting in approximately $329 per share. Artificial intelligence sector earnings remained aligned with consensus forecasts, while projections for other index components were reduced by 7.5%.
Economic Framework Underpinning the Forecast
Regarding economic variables, RBC incorporated inflation expectations of 3.3%, exceeding consensus estimates. The firm projected the Federal Reserve would maintain current interest rates while 10-year Treasury yields would stabilize around 4.5%.
These parameters generated an implied trailing price-to-earnings ratio of approximately 24 times earnings.
RBC acknowledged that averaging its five forecasting models would yield a higher target of 8,100. The firm selected 7,900 as its formal projection, stating this figure appropriately balances potential risks against remaining appreciation opportunities.
This adjustment aligns with recent upgrades from J.P. Morgan and Barclays during the previous month. Both institutions referenced diminishing geopolitical concerns and strengthening earnings trends as rationale for their revisions.
RBC maintained its emphasis on growth over value stocks within large-cap categories. The firm also expressed preference for U.S. equities relative to international markets and retained a measured positive stance on small-cap stocks.
Healthcare Sector Rating Reduced
RBC implemented one sector adjustment concurrent with its target increase. The firm lowered its rating on U.S. healthcare equities to Market Weight from Overweight.
The downgrade stemmed from worsening earnings revisions, substantial fund withdrawals, and disappointing findings in RBC’s latest analyst survey.
RBC outlined multiple risks to its projection. These include possible downward adjustments to 2027 earnings forecasts and elevated valuations within the semiconductor industry.
The firm identified Middle East geopolitical tensions as the most significant tail risk capable of triggering a U.S. recession. Nevertheless, RBC noted that most publicly traded corporations have indicated they can navigate through current disruptions.
The S&P 500 recorded its largest monthly percentage advance since November 2020 during the previous month.
